Ralph Niven is CSO at Aerovate Therapeutics, Inc. (AVTE). They have made 3 open-market trades across 1 company since 2022, most recently 2024-02-05.
CIK 0001168060
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AVTE | 6,209 | $17K |
Shares reported on the most recent Form 4, priced at the 2024-02-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AVTE | SELL · 10b5-1 | 2024-02-05 | 2024-02-07 | $17.45 | $80K | -9.7% | +27.4% | -1.8% |
| AVTE | SELL · 10b5-1 | 2024-01-05 | 2024-01-08 | $19.15 | $88K | +4.9% | +6.5% | +37.0% |
| AVTE | SELL · 10b5-1 | 2023-12-05 | 2023-12-07 | $16.30 | $75K | +15.2% | +17.8% | +41.9% |
| AVTE | SELL · 10b5-1 | 2023-11-22 | 2023-11-27 | $15.00 | $207K | +4.1% | +51.6% | +29.6% |
| AVTE | SELL · 10b5-1 | 2023-07-05 | 2023-07-07 | $17.29 | $39K | -7.2% | -12.6% | -22.0% |
| AVTE | SELL · 10b5-1 | 2023-06-05 | 2023-06-07 | $16.26 | $37K | -1.4% | +4.4% | -8.7% |
| AVTE | SELL · 10b5-1 | 2023-05-05 | 2023-05-09 | $20.87 | $47K | -16.2% | -24.7% | -31.0% |
| AVTE | SELL · 10b5-1 | 2023-04-05 | 2023-04-07 | $18.20 | $41K | -0.3% | +20.5% | -9.3% |
| AVTE | SELL | 2023-03-06 | 2023-03-08 | $23.74 | $106K | -13.2% | -24.2% | -31.9% |
| AVTE | SELL | 2023-02-06 | 2023-02-08 | $24.27 | $109K | +5.5% | -14.7% | -15.1% |
| AVTE | SELL | 2023-01-05 | 2023-01-09 | $26.40 | $59K | -3.0% | +3.9% | -26.3% |
| AVTE | SELL · 10b5-1 | 2022-12-05 | 2022-12-07 | $17.38 | $39K | +31.1% | +28.8% | +15.7% |
| AVTE | SELL · 10b5-1 | 2022-11-07 | 2022-11-09 | $19.19 | $43K | -2.2% | +37.7% | +42.1% |
| AVTE | SELL · 10b5-1 | 2022-10-05 | 2022-10-07 | $15.75 | $35K | +32.2% | +11.6% | +67.9% |
| AVTE | SELL · 10b5-1 | 2022-09-06 | 2022-09-07 | $19.00 | $43K | -13.3% | -9.7% | -0.7% |
| AVTE | SELL · 10b5-1 | 2022-08-18 | 2022-08-19 | $21.18 | $48K | -4.8% | -24.4% | -7.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.